Clinical Trials Directory

Trials / Completed

CompletedNCT00791687

Prenatal Corticosteroids and Antioxidants in Preterm Infants

Prenatal Corticosteroids Enhance the Antioxidant Defense System in Extremely Low Gestational Age Neonates

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
Fundacion Para La Investigacion Hospital La Fe · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Premature infants are highly susceptible to oxidative stress because of the immaturity of their antioxidant defense system. The use of prenatal glucocorticosteroids administered to the mother improves respiratory function and overall outcome. The investigators hypothesize that prenatal glucocorticosteroids favor the expression and competence of the antioxidant defense system.

Detailed description

This is an observational study recruiting extremely low gestational age neonates (\<28 weeks gestation) whose mothers received or not full scheduled prenatal glucocorticosteroids. Healthy term newly born infants acted as controls. At birth cord blood were drawn for the following analytical determinations: reduced and oxidized glutathione; malondialdehyde; superoxide dismutase; catalase; glutathione peroxidase; glutathione reductase; glutathione s-transferase. In addition, first urine voided was collected for ortho-tyrosine/phenylalanine and 8-hydroxy-2-oxo-deoxyguanosine/2-deoxyguanosine determination. Analytical data and clinical outcomes are compared.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2005-01-01
Completion
2005-01-01
First posted
2008-11-14
Last updated
2008-11-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00791687. Inclusion in this directory is not an endorsement.